Efficacy of Nitazoxanide in the Treatment of Chronic Hepatitis C Virus (HCV)

NCT01276756 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Chronic Hepatitis c

Interventions

DRUG: Pegylated interferon alfa-2a
DRUG: Nitazoxanide
DRUG: Ribavirin

Sponsor

Cairo University

Collaborators

[object Object]